TCM
GH icon

TD Capital Management’s Guardant Health GH Stock Holding History

TD Capital Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8
Closed -$817 – 878
2025
Q4 		$817 Hold
8
– – ﹤0.01% 678
2025
Q3 		$500 Hold
8
– – ﹤0.01% 653
2025
Q2 		$416 Hold
8
– – ﹤0.01% 665
2025
Q1 		$341 Buy
+8
New +$345 ﹤0.01% 615

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TD Capital Management's GH Position: Q1 2026 in Review

TD Capital Management sold out of Guardant Health (GH) in Q1 2026, closing a stake of 8 shares — an estimated $817 sold.

TD Capital Management first reported a position in GH in Q1 2025 and held it in 4 quarters. The position peaked at $817 in Q4 2025. 485 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • TD Capital Management reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
  • TD Capital Management sold 8 Guardant Health shares in Q1 2026, an estimated $817.
  • TD Capital Management first reported a position in Guardant Health in Q1 2025 and held it in 4 quarters.
  • TD Capital Management's Guardant Health position peaked at $817 in Q4 2025.
  • 485 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on TD Capital Management's 13F filing for Q1 2026, filed 11 May 2026.